Kestra Medical Technologies, Ltd. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Kestra Medical Technologies, Ltd. (KMTS) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $2.50 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-09-14
- 2026-07-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.50M.
- 2026-04-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.75M.
- 2026-01-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $4.13M.
- 2025-10-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $4.52M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2026-07-31 | $2.50M 10-Q · filed 2026-09-14 |
| 2026-04-30 | $3.75M 10-Q · filed 2026-09-14 |
| 2026-01-31 | $4.13M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $4.52M 10-Q · filed 2025-12-11 |
| 2025-07-31 | $4.91M 10-Q · filed 2025-09-12 |
| 2025-04-30 | $5.30M 10-K · filed 2026-07-14 |
| 2024-04-30 | $3.00M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |